|Bid||0.00 x 1000|
|Ask||0.00 x 900|
|Day's Range||1.2501 - 1.5399|
|52 Week Range||1.1200 - 5.5200|
|Beta (3Y Monthly)||0.47|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Yield10 Bioscience Inc (NASDAQ:YTEN), as the company does not have to adhere to strict debt covenants. However, it also faces Read More...
Yield10 Bioscience Inc’s (NASDAQ:YTEN): Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The US$12.9m market-cap company’sRead More...
Assessing Yield10 Bioscience Inc’s (NASDAQ:YTEN) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check toRead More...
Examining Yield10 Bioscience Inc’s (NASDAQ:YTEN) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations,Read More...
Yield10 Bioscience Inc (NASDAQ:YTEN) shares are shooting up 268% faster than Jack's magic bean sparking right into a giant beanstalk, thanks to today's news of a granted non-exclusive research license to Monsanto Company to evaluate the agricultural bioscience company's novel algal genes C3003 and C3004. Specifically, Monsanto intends to study these two yield traits within the scope of its soybean pipeline as a larger game plan to enhance plant yields. The name of the game for Yield10 is all about boosting seed yield as well as oil content in oilseed crops, which includes the likes of canola.